Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
$99/month membership required on top of medication cost Optional Support: Free text-based coaching included with all plans may include AI-generated responses monitored by a licensed coach
Book Consultation Engages both GLP-1 and GIP receptors at lower doses to support metabolic signaling, glucose regulation, and appetite communication without overwhelming the system
Liposomal Delivery That Actually Works Wrapped in phospholipid bubbles, these nutrients bypass your digestive system's breakdown process and go straight into your bloodstream
Adverse Reactions in Patients for Weight Reduction and Long-Term Maintenance Pool of Placebo-Controlled Weight Reduction Trials in Adults with Obesity or Overweight, with or without Type 2 Diabetes (Study 1 and Study 2) ZEPBOUND was evaluated for safety in a pool of two randomized, double-blind, placebo-controlled trials that included 2,519 adult patients with obesity or overweight treated with ZEPBOUND for up to 72 weeks and a 4-week off drug follow-up period (Study 1 and Study 2) [see Clinical Studies (14.1)]
Read our new solutions report to learn how Ipsos can help your business ask the right questions about GLP-1s and find the right answers through a total understanding of the science, the stakeholders, and the strategies that fuel sustainable growth
Fatigue or mild dizziness may occur, especially if caloric intake is too low
